JAMES GRANT BAILEY, L.AC.
Acupuncture at Montana Ave, Santa Monica, CA

License number

California AC6102

Professional information

James Bailey - Santa Monica, CA

Work:

Recreational Equipment Incorporated
Bike repair and Camping Sales Specialist Historic Home Renovation and Restoration Carpenter BB Jewelry Studio
Manager, Designer, Gold/Platinumsmith Carpenter - Construction
Designer-Goldsmith Baum Diamonds Johnny's Pizza
Manager Edwards Builders and Associates - Greenville, NC
General Carpentry Joe Pittman, John Bland - Durham, NC
Residential Framing Robert Tewksberry - Durham, NC
Residential Framing Residential Repair - Los Angeles, CA
Residential Framing C.C. Woods Construction Company
Construction Worker C.C. Woods Construction Company
Construction Worker Self employed
Residential Painter Self employed
Lawn Care Triangle Maintenance
Janitor/Maintenance

Education:

East Carolina University
Bachelor of Fine Arts in Metal Design North Carolina State University
Electrical and Civil Engineering Durham Technical College
Vertical Milling and Lathe work Wake Technical College

Skills:

Carpentry, Construction, Concrete Work, Metal Work, Electrical (non-licensed) Plumbing (non-licensed), Computer Skills; word, photshop, google sketchup, Model Building, Furniture design and construction.

James G Bailey, Santa Monica CA - LAC

Specialties:

Acupuncture

Address:

1502 Montana Ave STE 207, Santa Monica 90403
(310) 393-4124 (Phone), (310) 393-4124 (Fax)

Languages:

English

James Grant Bailey, Santa Monica CA

Specialties:

Acupuncturist

Address:

1502 Montana Ave, Santa Monica, CA 90403

Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity

US Patent:

2011029, Dec 1, 2011

Filed:

Dec 23, 2010

Appl. No.:

12/977843

Inventors:

Pablo UMANA - Manchester, GB
Joel Jean-Mairet - Barcelona, ES
James E. Bailey - Santa Monica CA, US

Assignee:

Roche GlycArt AG - Schlieren-Zurich

International Classification:

C07K 16/18, C07K 16/40, C12P 21/00, C07K 16/00

US Classification:

5303873, 435 681

Abstract:

The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.

Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity

US Patent:

2011014, Jun 16, 2011

Filed:

May 28, 2010

Appl. No.:

12/790716

Inventors:

PABLO UMAÑA - ZURICH, CH
JOËL JEAN-MAIRET - BARCELONA, ES
JAMES E. BAILEY - SANTA MONICA CA, US
M. SEAN BAILEY - SANTA MONICA CA, US

Assignee:

ROCHE GLYCART AG - SCHLIEREN-ZURICH

International Classification:

A61K 39/395, C07K 16/30, A61P 35/00

US Classification:

4241331, 5303873

Abstract:

Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity

US Patent:

8021856, Sep 20, 2011

Filed:

Aug 9, 2005

Appl. No.:

11/199232

Inventors:

Pablo Umaña - Zurich, CH
Joël Jean-Mairet - Barcelona, CH
James E. Bailey - Santa Monica CA, US

Assignee:

Roche GlycArt AG - Zürich

International Classification:

C12P 21/08, A61K 39/395

US Classification:

435 691, 4241301, 435 7021

Abstract:

The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.